ACP5 and osteosarcoma: Regardless of the proportion of each cluster, we observed that pro-osteoclast signatures were consistently elevated in all clusters following chemotherapy, as evidenced by differentially expressed genes (DEGs), such as CTSK and ACP5, when comparing osteosarcomas post-chemotherapy with those before treatment (Fig. 5I).